Bionime Corporation (4737.TW) TAI

63.70

-0.8(-1.26%)

Updated at September 26 02:36PM

Currency In TWD

Valuation

Market Cap3.94B
Enterprise Value6.79B
P/E Ratio-37.86
PEG Ratio-2.38
Price/Sales Ratio2.2
Price/Book Ratio2.29
Enterprise/Revenue3.6
Enterprise/EBITDA71.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.06
Operating Margin-0.07

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.06

Income Statement

Revenue1.93B
Revenue/Share28.77
Gross Profit768.38M
EBITDA59.29M
Net Income-127.22M
Diluted EPS-1.91

Balance Sheet

Total Cash374.99M
Total Cash/Share5.55
Total Debt3.03B
Total Debt/Equity1.61
Current Ratio0.8
Book Value Per Share27.98

Price History

52-Week Change1.3
52-Week High73.9
52-Week Low43.14
Moving Average 50 Days67.27
Moving Average 200 Days61.56

Statistics

Average Volume99,408
Shares Outstanding67.14M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-1.07
Last Split Factor1099:1000
Last Split DateSeptember 08, 2025